Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
Lisi Deng, Chunna Li, Qi Zeng, Xi Liu, Xinghua Li, Haitang Zhang, Zhongsi Hong, Jinyu Xia
Topics & Concepts
LopinavirMedicineRitonavirRetrospective cohort studyCoronavirus disease 2019 (COVID-19)Internal medicineLopinavir/ritonavirClinical endpointPneumoniaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Single CenterCohortGastroenterologySurgeryViral loadDiseaseVirusClinical trialVirologyAntiretroviral therapyInfectious disease (medical specialty)COVID-19 Clinical Research StudiesPharmacological Receptor Mechanisms and EffectsRespiratory viral infections research